Russell R Ferlita

Title: The Innovative Contributions of Russell R. Ferlita

Introduction

Russell R. Ferlita is a notable inventor based in Westfield, NJ (US), recognized for his significant contributions to pharmaceutical sciences. He holds a total of 5 patents, showcasing his expertise in developing innovative solutions for various health conditions.

Latest Patents

Ferlita's latest patents include groundbreaking work on crystalline forms of an inhibitor of 11-β-hydroxysteroid dehydrogenase type 1. These novel crystalline salts are identified as potent inhibitors and are particularly useful for treating conditions associated with Metabolic Syndrome and cognitive impairment. His invention also encompasses pharmaceutical compositions containing these salts, along with processes for their preparation and applications in treating Type 2 diabetes, hyperglycemia, obesity, dyslipidemia, hypertension, and cognitive impairment. Another significant patent involves the synthesis of N-{(1S)-1-[2-(1-{[(3S,4R)-1-tert-butyl-4-(2,4-difluorophenyl)pyrrolidin-3-yl]carbonyl}piperidin-4-yl)-5-chlorophenyl]ethyl}acetamide, which includes novel crystalline salts, hydrates, solvates, and polymorphic forms.

Career Highlights

Throughout his career, Ferlita has worked with prominent companies in the pharmaceutical industry, including Merck Sharp & Dohme Corporation and Merck & Company, Inc. His work has significantly impacted the development of treatments for various metabolic and cognitive disorders.

Collaborations

Ferlita has collaborated with esteemed colleagues such as Robert Wenslow and Stephen Howard Cypes, contributing to the advancement of pharmaceutical innovations.

Conclusion

Russell R. Ferlita's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a key innovator in addressing critical health challenges. His work continues to influence the development of effective treatments for complex conditions.